{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:10:13Z","timestamp":1791155413001,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T00:00:00Z","timestamp":1359417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s00262-013-1395-9","type":"journal-article","created":{"date-parts":[[2013,1,28]],"date-time":"2013-01-28T08:06:11Z","timestamp":1359360371000},"page":"863-873","source":"Crossref","is-referenced-by-count":31,"title":["Increased prevalence of tumour infiltrating immune cells in oropharyngeal tumours in comparison to other subsites: relationship to peripheral immunity"],"prefix":"10.1007","volume":"62","author":[{"given":"Victoria L.","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Michno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas D.","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Greenman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,29]]},"reference":[{"key":"1395_CR1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics 2002. CA Cancer J Clin 55:74\u2013108","journal-title":"CA Cancer J Clin"},{"key":"1395_CR2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-T\u00e2n PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24\u201335. doi: 10.1056\/NEJMoa0912217","journal-title":"N Engl J Med"},{"key":"1395_CR3","author":"A Duray","year":"2010","unstructured":"Duray A, Demoulin S, Hubert P, Delvenne P, Saussez S (2010) Immune suppression in head and neck cancers: a review. Clin Dev Immunol. doi: 10.1155\/2010\/701657","journal-title":"Clin Dev Immunol"},{"key":"1395_CR4","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/j.jaci.2009.09.045","volume":"125","author":"TL Whiteside","year":"2010","unstructured":"Whiteside TL (2010) Immune responses to malignancies. J Allergy Clin Immunol 125:S272\u2013S283","journal-title":"J Allergy Clin Immunol"},{"key":"1395_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2011.12.004","volume":"273","author":"N Junker","year":"2012","unstructured":"Junker N, Kvistborg P, K\u00f8llgaard T, Pt Straten, Anderson MH (2012) Tumor associated antigen specific T-cell populations identified in ex vivo expanded TIL cultures. Cell Immunol 273:1\u20139. doi: 10.1016\/j.jaci.2009.09.045","journal-title":"Cell Immunol"},{"key":"1395_CR6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman WH, Pages F, Sautes-Fridman C, Galon J (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12:298\u2013306. doi: 10.1038\/nrc3245","journal-title":"Nat Rev Cancer"},{"key":"1395_CR7","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1158\/1078-0432.CCR-11-3216","volume":"18","author":"RJ deLeeuw","year":"2012","unstructured":"deLeeuw RJ, Kost SE, Kakal JA, Nelson BH (2012) The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature. Clin Cancer Res 18:3022\u20133029. doi: 10.1158\/1078-0432.CCR-11-3216","journal-title":"Clin Cancer Res"},{"key":"1395_CR8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2011.09.039","volume":"124","author":"WT Hwang","year":"2012","unstructured":"Hwang WT, Adams SF, Tahirovic E, Hagemann IS, Coukos G (2012) Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis. Gynecol Oncol 124:192\u2013198. doi: org\/10.1016\/j.ygyno.2011.09.039","journal-title":"Gynecol Oncol"},{"key":"1395_CR9","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1365-2559.2011.04040.x","volume":"59","author":"D Anz","year":"2011","unstructured":"Anz D, Eiber S, Sholtz C, Endres S, Kirchner T, Bourquin C, Mayr D (2011) In breast cancer, a high ratio of tumour-infiltrating intraepithelial CD8+ to FoxP3+ cells is characteristic for the medullary subtype. Histopathology 59:965\u2013974. doi: 10.1111\/j.1365-2559.2011.04040.x","journal-title":"Histopathology"},{"key":"1395_CR10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/1471-2407-9-292","volume":"9","author":"D Pretscher","year":"2009","unstructured":"Pretscher D, Distel LV, Grabenbauer GG, Wittlinger M, Buettner M, Niedobitek G (2009) Distribution of immune cells in head and neck cancer: CD8+ T cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma. BMC Cancer 9:292\u2013302. doi: 10.1186\/1471-2407-9-292","journal-title":"BMC Cancer"},{"key":"1395_CR11","first-page":"16","volume":"8","author":"R Uppaluri","year":"2008","unstructured":"Uppaluri R, Dunn GP, Lewis JS (2008) Focus on TILs: prognostic significance of tumour infiltrating lymphocytes in head and neck cancers. Cancer Immunol 8:16\u201325","journal-title":"Cancer Immunol"},{"key":"1395_CR12","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1517\/14712598.2010.482207","volume":"10","author":"TL Whiteside","year":"2010","unstructured":"Whiteside TL (2010) Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression. Expert Opin Biol Ther 10:1019\u20131035. doi: 10(1517\/14712598).2010.482207","journal-title":"Expert Opin Biol Ther"},{"key":"1395_CR13","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00262-011-1012-8","volume":"60","author":"I Poschke","year":"2011","unstructured":"Poschke I, Mougiakakos D, Kiessling R (2011) Camouflage and sabotage: tumor escape from the immune system. Cancer Immunol Immunother 60:1161\u20131171. doi: 10.1007\/s00262-011-1012-8","journal-title":"Cancer Immunol Immunother"},{"key":"1395_CR14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674. doi: 10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"1395_CR15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/hed.20739","volume":"30","author":"O Alhamarneh","year":"2008","unstructured":"Alhamarneh O, Amarnath SMP, Stafford ND, Greenman J (2008) Regulatory T-cells: what role do they play in antitumour immunity in patients with head and neck cancer? Head Neck 30:251\u2013261. doi: 10.1002\/hed.20739","journal-title":"Head Neck"},{"key":"1395_CR16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","volume":"10","author":"S Sakaguchi","year":"2010","unstructured":"Sakaguchi S, Miyara M, Costantino CM, Hafler DA (2010) FoxP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10:490\u2013500. doi: 10.1038\/nri2785","journal-title":"Nat Rev Immunol"},{"key":"1395_CR17","first-page":"833","volume":"40","author":"VL Green","year":"2012","unstructured":"Green VL, Irune E, Prasai A, Alhamarneh O, Greenman J, Stafford ND (2012) Serum IL10, IL12 and circulating CD4+CD25high T regulatory cells in relation to long-term clinical outcome in head and neck squamous cell carcinoma patients. Int J Oncol 40:833\u2013839. doi: 10.3892\/ijo.2011.1259","journal-title":"Int J Oncol"},{"key":"1395_CR18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.bjc.6603580","volume":"96","author":"KM Lau","year":"2007","unstructured":"Lau KM, Cheng SH, Lo KW, Lee SA, Woo JK, van Hasselt CA, Lee SP, Rickinson AB, Ng MH (2007) Increase in circulating Foxp3+CD4+CD25(high) regulatory T cells in nasopharyngeal carcinoma patients. Br J Cancer 96:617\u2013622. doi: 10.1038\/sj.bjc.6603580","journal-title":"Br J Cancer"},{"key":"1395_CR19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1582-4934.2008.00650.x","volume":"14","author":"J Boucek","year":"2010","unstructured":"Boucek J, Mrkvan T, Chovanec M, Kuchar M, Betka J, Boucek V, Hladikova M, Betka J, Eckschlager T, Rihova B (2010) Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck. J Cell Mol Med 14:426\u2013433. doi: 10.1111\/j.1582-4934.2008.00650.x","journal-title":"J Cell Mol Med"},{"key":"1395_CR20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1158\/1078-0432.CCR-05-1886","volume":"12","author":"C Badoual","year":"2006","unstructured":"Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, Agueznay Nel H, Mosseri V, Laccourreye O, Bruneval P, Fridman WH, Brasnu DF, Tartour E (2006) Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res 12:465\u2013472. doi: 10.1158\/1078-0432.CCR-05-1886","journal-title":"Clin Cancer Res"},{"key":"1395_CR21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/cbr.2007.0373","volume":"23","author":"D Loose","year":"2008","unstructured":"Loose D, Signore A, Bonanno E, Vermeersch H, Dierckx R, Deron P, Van de Wiele C (2008) Prognostic value of CD25 expression on lymphocytes and tumor cells in squamous-cell carcinoma of the head and neck. Cancer Biother Radiopharm 23:25\u201333. doi: 10.1089\/cbr.2007.0373","journal-title":"Cancer Biother Radiopharm"},{"key":"1395_CR22","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.2741\/e509","volume":"4","author":"F Briest","year":"2012","unstructured":"Briest F, Berndt A, Clement J, Eggeling F, Grimm S, Friedrich K (2012) Tumour-stroma interactions in tumorigenesis:lessons from stem cell biology. Front Biosci (Elite Ed) 4:1871\u20131887. doi: org\/10.2741\/509","journal-title":"Front Biosci (Elite Ed)"},{"key":"1395_CR23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/bjc.2011.517","volume":"106","author":"D Basanta","year":"2012","unstructured":"Basanta D, Scott JG, Fishman MN, Ayala G, Hayward SW, Anderson ARA (2012) Investigating prostate cancer tumour-stroma interactions: clinical and biological insights from an evolutionary game. Br J Cancer 106:174\u2013181. doi: 10.1038\/bjc.2011.517","journal-title":"Br J Cancer"},{"key":"1395_CR24","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/jcb.21159","volume":"101","author":"H Li","year":"2007","unstructured":"Li H, Fan X, Houghton JM (2007) Tumor Microenvironment: the role of the tumour stroma in cancer. J Cell Biochem 101:805\u2013815. doi: 10.1002\/jcb.21159","journal-title":"J Cell Biochem"},{"key":"1395_CR25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/hed.21464","volume":"33","author":"O Alhamarneh","year":"2011","unstructured":"Alhamarneh O, Agada F, Madden L, Stafford N, Greenman J (2011) Serum IL10 and circulating CD4(+)CD25(high) regulatory T cell numbers as predictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma. Head Neck 33:415\u2013423. doi: 10.1002\/hed.21464","journal-title":"Head Neck"},{"key":"1395_CR26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1021\/mp1004228","volume":"8","author":"EA Vasievich","year":"2011","unstructured":"Vasievich EA, Huang L (2011) The suppressive tumor microenvironment: a challenge in cancer immunotherapy. Mol Pharm 8:635\u2013641. doi: 10.1021\/mp1004228","journal-title":"Mol Pharm"},{"key":"1395_CR27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nrc3186","volume":"12","author":"MA Swartz","year":"2012","unstructured":"Swartz MA, Lund AW (2012) Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nat Rev Cancer 12:210\u2013219. doi: 10.1038\/nrc3186","journal-title":"Nat Rev Cancer"},{"key":"1395_CR28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12105-009-0100-y","volume":"3","author":"WH Westra","year":"2009","unstructured":"Westra WH (2009) The changing face of head and neck cancer in the 21st century: the impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol 3:78\u201381. doi: 10.1007\/s12105-009-0100-y","journal-title":"Head Neck Pathol"},{"key":"1395_CR29","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/j.oraloncology.2009.05.640","volume":"45","author":"LV Distel","year":"2009","unstructured":"Distel LV, Fickenscher R, Dietel K, Hung A, Iro H, Zenk J, Nkenke E, B\u00fcttner M, Niedobitek G, Grabenbauer GG (2009) Tumour infiltrating lymphocytes in squamous cell carcinoma of the oro- and hypopharynx: prognostic impact may depend on type of treatment and stage of disease. Oral Oncol 45:e167\u2013e174. doi: 10.1016\/j.oraloncology.2009.05.640","journal-title":"Oral Oncol"},{"key":"1395_CR30","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1470-2045(10)70017-6","volume":"11","author":"S Marur","year":"2010","unstructured":"Marur S, D\u2019Souza G, Westra WH, Forastiere AA (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11:781\u2013789. doi: 10.1016\/S1470-2045(10)70017-6","journal-title":"Lancet Oncol"},{"key":"1395_CR31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1749-4486.2006.01246.x","volume":"31","author":"CGL Hobbs","year":"2006","unstructured":"Hobbs CGL, Sterne JAC, Bailey M, Heyderman RS, Birchall MA, Thomas SJ (2006) Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 31:259\u2013266. doi: 10.1111\/j.1749-4486.2006.01246.x","journal-title":"Clin Otolaryngol"},{"key":"1395_CR32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","volume":"14","author":"AR Kreimer","year":"2005","unstructured":"Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14:467\u2013475. doi: 10.1158\/1055-9965.EPI-04-0551","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1395_CR33","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.clon.2010.05.024","volume":"22","author":"M Evans","year":"2010","unstructured":"Evans M, Powell NG (2010) The changing aetiology of head and neck cancer: the role of human papillomavirus. Clin Oncol 22:538\u2013546. doi: 10.1016\/j.clon.2010.05.024","journal-title":"Clin Oncol"},{"key":"1395_CR34","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/ijc.21565","volume":"118","author":"TK Hoffmann","year":"2006","unstructured":"Hoffmann TK, Arsov C, Schirlau K, Bas M, Friebe-Hoffmann U, Klussmann JP, Scheckenbach K, Balz V, Bier H, Whiteside TL (2006) T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx. Int J Cancer 118:1984\u20131991. doi: 10.1002\/ijc.21565","journal-title":"Int J Cancer"},{"key":"1395_CR35","doi-asserted-by":"crossref","first-page":"6301","DOI":"10.1158\/1078-0432.CCR-07-1403","volume":"13","author":"L Strauss","year":"2007","unstructured":"Strauss L, Bergmann C, Gooding W, Johnson JT, Whiteside TL (2007) The frequency and suppressor function of CD4+CD25highFoxp3+T cells in the circulation of patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 13:6301\u20136311. doi: 10.1158\/1078-0432.CCR-07-1403","journal-title":"Clin Cancer Res"},{"key":"1395_CR36","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","volume":"27","author":"TL Whiteside","year":"2008","unstructured":"Whiteside TL (2008) The tumour microenvironment and its role in promoting tumour growth. Oncogene 27:5904\u20135912. doi: 10.1038\/onc.2008.271","journal-title":"Oncogene"},{"key":"1395_CR37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10549-012-2132-3","volume":"135","author":"F Liu","year":"2012","unstructured":"Liu F, Li Y, Ren M, Zhang X, Guo X, Lang R, Gu F, Fu L (2012) Peritumoral FOXP3+ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3+ regulatory T cell is prognostic predictor of breast cancer patients. Breast Cancer Res Treat 135:459\u2013467. doi: 10.1038\/onc.2008.271","journal-title":"Breast Cancer Res Treat"},{"key":"1395_CR38","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/eji.201040913","volume":"41","author":"CT Mayer","year":"2011","unstructured":"Mayer CT, Floess S, Baru AM, Lahl K, Huehn J, Sparwasser T (2011) CD8+FoxP3+ Tcells share developmental and phenotypic features with classical CD4+FoxP3+ regulatory T cells but lack potent suppressive activity. Eur J Immunol 41:716\u2013725. doi: 10.1002\/eji.201040913","journal-title":"Eur J Immunol"},{"key":"1395_CR39","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/eji.200838168","volume":"38","author":"MG Roncarlo","year":"2008","unstructured":"Roncarlo MG, Gregori S (2008) Is FOXP3 a bona fide marker for human regulatory T cells? Eur J Immunol 38:925\u2013927. doi: 10.1002\/eji.200838168","journal-title":"Eur J Immunol"},{"key":"1395_CR40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1479-5876-6-19","volume":"6","author":"V Karanikas","year":"2008","unstructured":"Karanikas V, Speletas M, Zamanakou M, Kalala F, Loules G, Kerenidi T, Barda AK, Gourgoulianis KI, Germenis AE (2008) FoxP3 expression in human cancer cells. J Transl Med 6:19\u201326. doi: 10.1186\/1479-5876-6-19","journal-title":"J Transl Med"},{"key":"1395_CR41","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/ijc.23001","volume":"121","author":"L Strauss","year":"2007","unstructured":"Strauss L, Bergmann C, Whiteside TL (2007) Functional and phenotypic characteristics of CD4+CD25HighFoxp3+Treg clones obtained from peripheral blood of patients with cancer. Int J Cancer 121:2473\u20132483. doi: 10.1002\/ijc.23001","journal-title":"Int J Cancer"},{"key":"1395_CR42","first-page":"67","volume":"26","author":"AK Schott","year":"2010","unstructured":"Schott AK, Pries R, Wollenberg B (2010) Permanent up-regulation of regulatory T-lymphocytes in patients with head and neck cancer. Int J Mol Med 26:67\u201375. doi: 10.3892\/ijmm_00000436","journal-title":"Int J Mol Med"},{"key":"1395_CR43","doi-asserted-by":"crossref","first-page":"e24671","DOI":"10.1371\/journal.pone.0024671","volume":"6","author":"KJ Chen","year":"2011","unstructured":"Chen KJ, Lin SZ, Zhou Z, Xie HY, Zhou WH, Taki-Eldin A, Zheng SS (2011) Selective Recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis. PLoS ONE 6:e24671. doi: 10.1371\/journal.pone.0024671","journal-title":"PLoS ONE"},{"key":"1395_CR44","doi-asserted-by":"crossref","unstructured":"Gasparoto TH, de Souza Malaspina TS, Benevides L, de Melo EJ Jr, Costa MR, Damante JH, Ikoma MR, Garlet GP, Cavassani KA, da Silva JS, Campanelli AP (2010) Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment. Cancer Immunol Immunother 59:819\u2013828. doi: 10.1007\/s00262-009-0803-7","DOI":"10.1007\/s00262-009-0803-7"},{"key":"1395_CR45","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1158\/1078-0432.CCR-07-0472","volume":"13","author":"L Strauss","year":"2007","unstructured":"Strauss L, Bergmann C, Szczepanski M, Gooding W, Johnson JT, Whiteside TL (2007) A unique subset of CD4+CD25highFoxP3+T cells secreting interleukin-10 and transforming growth factor-B1 mediates suppression in the tumor microenvironment. Clin Cancer Res 13:4345\u20134354. doi: 10.1158\/1078-0432.CCR-07-0472","journal-title":"Clin Cancer Res"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-013-1395-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-013-1395-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-013-1395-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T03:15:56Z","timestamp":1714878956000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-013-1395-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,29]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["1395"],"URL":"https:\/\/doi.org\/10.1007\/s00262-013-1395-9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717991594.793473419","asserted-by":"object"}]},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,29]]}}}